---
title: "3D Systems reports $95 million revenues in Q1 2025, -8%"
url: https://www.voxelmatters.com/3d-systems-reports-95-million-revenues-in-q1-2025-8/
date: 2025-05-14
modified: 2025-05-14
lang: en
author: "Davide Sher"
description: "3D Systems Corporation (NYSE:DDD) reported revenues of $94.5 million for Q1 2025, which ended March 31, marking an 8% decrease compared to last year. The decline in material sales, primarily..."
categories:
  - "AM Industry Analysis and Market Data"
  - "Financial Reports"
  - "Money & Funding"
tags:
  - "insights"
image: https://www.voxelmatters.com/wp-content/uploads/2024/11/3d-systems-sla-750-hero-gray-screen-640x364.png
word_count: 383
---

# 3D Systems reports $95 million revenues in Q1 2025, -8%

[3D Systems Corporation (NYSE:DDD)](https://www.voxelmatters.directory/company/3d-systems/) reported revenues of $94.5 million for Q1 2025, which ended March 31, marking an 8% decrease compared to last year. The decline in material sales, primarily due to inventory adjustments in the dental aligner market, offset the growth in hardware and services.

Despite the revenue drop, the company highlighted several positives and concrete strategies to navigate current challenges. Notably, the increase in new printer sales, driven by the latest hardware systems, stood out. Advanced metal 3D printing solutions achieved significant traction, particularly in the Aerospace and Defense sectors—reliable segments with strong growth potential.

![Explore the financial results of 3D Systems Q1 2025, revealing an 8% revenue drop but promising growth in new printer sales.](https://www.voxelmatters.com/wp-content/uploads/2025/04/cranial-implant-3d-systems-1.jpeg)3D Systems PEEK facial implant point-of-care

Simultaneously, 3D Systems’ Healthcare division showed remarkable resilience. Despite a sluggish economy, the company achieved 17% growth in personalized healthcare and 18% in FDA-approved manufacturing operations, underscoring the importance of personalized medicine and biomedical applications in its long-term strategy.

Lower volumes and less favorable product mix impacted profitability. However, management responded proactively with targeted cost-saving measures. Following the $50 million cost-saving plan slated for completion by mid-2026, 3D Systems introduced an additional initiative to generate $20 million in savings during 2025. These measures are intended to align the organization with the current market demand and mitigate macroeconomic and tariff-related risks.

In the first quarter, operating expense reductions contributed approximately $5 million in year-over-year improvements, demonstrating that the cost-containment efforts are already yielding results. The company also plans to streamline operations by modernizing administrative functions and restructuring its workforce.

Another positive development is the strengthened balance sheet. The sale of the Geomagic portfolio in April generated over $100 million in post-tax proceeds, boosting cash reserves to around $250 million. This financial cushion supports ongoing operations and future growth initiatives.

The company has withdrawn its full-year guidance for 2025 due to uncertainties surrounding customer capital expenditure. Still, 3D Systems remains confident in its robust, newly revamped product portfolio, which is expected to be a competitive advantage as industrial investments rebound.

In conclusion, CEO Dr. Jeffrey Graves reaffirmed the company’s strategic vision—being a technology leader in metals and polymers with end-to-end control over design, production, and sourcing. While short-term challenges demand decisive action and cost discipline, the long-term shift toward localized manufacturing and increasing global demand for customized 3D solutions offer strong potential for value creation across stakeholder groups.